# Pilot Assessment of EyeArt as an Automated Diabetic Retinopathy Screening Tool

> **NCT03078231** · — · COMPLETED · sponsor: **Eyenuk, Inc.** · enrollment: 52 (actual)

## Conditions studied

- Diabetic Retinopathy

## Interventions

- **PROCEDURE:** Color fundus photography
- **DRUG:** Mydriatic Agent

## Key facts

- **NCT ID:** NCT03078231
- **Lead sponsor:** Eyenuk, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-17
- **Primary completion:** 2017-04-24
- **Final completion:** 2017-04-24
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2018-07-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03078231

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03078231, "Pilot Assessment of EyeArt as an Automated Diabetic Retinopathy Screening Tool". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03078231. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*